Author

Wenxin Ding

Institutions: First Affiliated Hospital of University of South China, Xiangxi Tujia and Miao Autonomous Prefecture People's Hospital, University of South China

Observed institutions: Central South University, Jishou University, First Affiliated Hospital of University of South China, Third Xiangya Hospital, Xiangxi Tujia and Miao Autonomous Prefecture People's Hospital, University of South China

ORCID: 0009-0002-0380-4752

Observed ORCID: 0009-0002-0380-4752

OpenAlex ID: A5114235508

Enhancement of Prognostic Outcomes in Stage III Non-Small Cell Lung Cancer: A Retrospective Study on Neoadjuvant Immuno-Chemotherapy Followed by Definitive Chemo-Radiotherapy

2025 · Wenxin Ding, Yechen Ma, et al. · Translational Oncology · 8

Is clinical target volume necessary for locally advanced non-small cell lung cancer treated with 4D-CT intensity-modulated radiation therapy

2024 · Wenxin Ding, Tian Xu, et al. · BMC Cancer · 3

Omission of clinical target volume in radiotherapy for unresectable stage III non-small cell lung cancer: a propensity score matching analysis

2026 · Wenxin Ding, Jing Liang, et al. · Annals of Medicine · 1

Machine learning‑based construction of damage‑associated molecular patterns related score identifies subtypes of pancreatic adenocarcinoma with distinct prognosis

2025 · Jing Liang, Hui Wu, et al. · Oncology Letters · 1

A Palmitoylation-Associated lncRNA Signature as a Prognostic Biomarker and Its Correlation With the Immune Microenvironment in Lung Adenocarcinoma

2026 · Wenxin Ding, Sixuan Wu, et al. · Frontiers in Bioscience-Landmark

Works count: 5

Citation count: 13

H-index: 2

I10-index: